The global landscape of bladder cancer incidence and mortality in 2020 and projections to 2040

被引:11
|
作者
Zhang, Yanting [1 ,4 ]
Rumgay, Harriet [2 ]
Li, Mengmeng [3 ]
Yu, Haibing [1 ]
Pan, Haiyan [1 ]
Ni, Jindong [1 ]
机构
[1] Guangdong Med Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Dongguan, Peoples R China
[2] Int Agcy Res Canc, Canc Surveillance Branch, Lyon, France
[3] Sun Yat sen Univ, Canc Ctr, Dept Canc Prevent, State Key Lab Oncol South China,Collaborat Innovat, Guangzhou, Peoples R China
[4] Guangdong Med Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, 1 Xincheng Rd, Dongguan, Peoples R China
基金
中国国家自然科学基金;
关键词
SMOKING; RISK; BURDEN; EUROPE; HEALTH; TRENDS;
D O I
10.7189/jogh.13.04109
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Bladder cancer (BCa) is one of the most common urological malignancies worldwide. This study examines the global epidemiological profile of BCa incidence and mortality in 2020 and the projected burden to 2040.Methods The estimated number of BCa cases and deaths were extracted from the GLOBOCAN 2020 database. Age-standardised incidence rates (ASIRs) and age-standardised mortality rates (ASMRs) were calculated using the world standard. The predicted BCa incidence and mortality in 2040 was calculated based on demo-graphic projections.Results Globally, approximately 573 000 new BCa cases and 213 000 deaths occurred in 2020, corresponding to ASIRs and ASMRs of 5.6 and 1.9 per 100 000, respectively. The incidence and mortality rates were approximately 4-fold higher in men (9.5 and 3.3 per 100 000, respectively) than women (2.4 and 0.9, respectively). Across world regions, incidence rates varied at least 12-fold among men and 8-fold among women, with the highest ASIRs for both men and women detected in Southern Europe (26.5 and 5.8 per 100 000, respectively) and Western Europe (21.5 and 5.8, respectively) and the lowest in Middle Africa (2.2) in men and South-Central Asia (0.7) in women. The highest ASMRs for both men and women were found in Northern Africa (9.2 and 1.8 per 100 000, respectively). By 2040, the annual number of new BCa cases and deaths will increase to 991 000 (72.8% increase from 2020) and 397 000 (86.6% increase), respectively. Conclusions Geographical distributions of BCa incidence and mortality uncovered higher risk of BCa incidence in Southern and Western European populations and higher risk of mortality in Northern African populations.Considering the predicted 73% and 87% increase in annual BCa cases and deaths by 2040 globally, respectively, there is an urgent need to develop and accelerate BCa control initiatives for high-risk populations to tackle global BCa burden and narrow its geographical disparities.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Mapping of global, regional and national incidence, mortality and mortality-to-incidence ratio of lung cancer in 2020 and 2050
    Sharma, Rajesh
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2022, 27 (04) : 665 - 675
  • [22] Global prediction of primary liver cancer incidences and mortality in 2040
    Li, Chenxi
    He, Wen-Qian
    [J]. JOURNAL OF HEPATOLOGY, 2023, 78 (04) : E144 - E146
  • [23] The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020
    Pizzato, Margherita
    Li, Mengmeng
    Vignat, Jerome
    Laversanne, Mathieu
    Singh, Deependra
    La Vecchia, Carlo
    Vaccarella, Salvatore
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2022, 10 (04): : 264 - 272
  • [24] Cancer Incidence and Mortality Through 2020
    Weir, Hannah K.
    White, Mary C.
    [J]. PREVENTING CHRONIC DISEASE, 2016, 13
  • [25] Current and future burden of breast cancer: Global statistics for 2020 and 2040
    Arnold, Melina
    Morgan, Eileen
    Rumgay, Harriet
    Mafra, Allini
    Singh, Deependra
    Laversanne, Mathieu
    Vignat, Jerome
    Gralow, Julie R.
    Cardoso, Fatima
    Siesling, Sabine
    Soerjomataram, Isabelle
    [J]. BREAST, 2022, 66 : 15 - 23
  • [26] Differences in the incidence and mortality of digestive cancer between Global Cancer Observatory 2020 and Global Burden of Disease 2019
    Yu, Ziqing
    Bai, Xiaoyin
    Zhou, Runing
    Ruan, Gechong
    Guo, Mingyue
    Han, Wei
    Jiang, Shiyu
    Yang, Hong
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2024, 154 (04) : 615 - 625
  • [27] Cancer incidence and mortality projections in the UK until 2035
    Smittenaar, C. R.
    Petersen, K. A.
    Stewart, K.
    Moitt, N.
    [J]. BRITISH JOURNAL OF CANCER, 2016, 115 (09) : 1147 - 1155
  • [28] Cancer incidence and mortality projections in the UK until 2035
    C R Smittenaar
    K A Petersen
    K Stewart
    N Moitt
    [J]. British Journal of Cancer, 2016, 115 : 1147 - 1155
  • [29] Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative
    Singh, Deependra
    Vignat, Jerome
    Lorenzoni, Valentina
    Eslahi, Marzieh
    Ginsburg, Ophira
    Lauby-Secretan, Beatrice
    Arbyn, Marc
    Basu, Partha
    Bray, Freddie
    Vaccarella, Salvatore
    [J]. LANCET GLOBAL HEALTH, 2023, 11 (02): : E197 - E206
  • [30] Global variation in cancer incidence and mortality
    Notani, PN
    [J]. CURRENT SCIENCE, 2001, 81 (05): : 465 - 474